Essex Investment Management CO LLC Iovance Biotherapeutics, Inc. Transaction History

Essex Investment Management CO LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 04, 2020	SELL	$19.54 - $38.85 $636,867 - $1.27 Million	-32,593 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$17.95 - $29.41 $6,479 - $10,617	361 Added 1.12%	32,593 $902,000
Q3 2019 Oct 22, 2019	BUY	$17.99 - $26.0 $579,853 - $838,032	32,232 New	32,232 $587,000

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.